Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

被引:34
作者
Rafati, S [1 ]
Nakhaee, A
Taheri, T
Ghashghaii, A
Salmanian, AH
Jimenez, M
Mohebali, M
Masina, S
Fasel, N
机构
[1] Inst Pasteur, Dept Immunol, Tehran, Iran
[2] Natl Res Ctr Genet Engn & Biotechnol, Tehran, Iran
[3] Natl Res Ctr Genet Engn & Biotechnol, Tehran, Iran
[4] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Parasitol, WHO Collaborating Ctr Leishmaniasis, Madrid, Spain
[5] Univ Tehran, Sch Publ Hlth, Tehran, Iran
[6] Univ Lausanne, Inst Biochem, Lausanne, Switzerland
关键词
Leishmania infantum; cysteine proteinases type I and II; visceral leishmaniasis; dog; human;
D O I
10.1016/S0014-4894(03)00097-3
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In this study, the mature domains of type I (CPB) and type 11 (CPA) cysteine proteinases (CPs) of Leishmania infantum were expressed and their immunogenic properties defined using sera from active and recovered cases of human visceral leishmaniasis and sera from infected dogs. Immunoblotting and ELISA analysis indicated that a freeze/thaw extract of parasite antigens showed similar and intensive recognition in both active cases of human and dog sera but lower recognition in recovered human individuals. The total IgG of actively infected human sera was higher than in recovered cases when rCPs were used as antigen. In contrast to dog sera, both active and recovered human cases have higher recognition toward rCPB than rCPA. Furthermore, the asymptomatic dogs in contrast to the symptomatic cases exhibited specific lymphocyte proliferation to both crude antigens and rCPs. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 36 条
[21]  
Rafati S, 1997, CLIN EXP IMMUNOL, V110, P203
[22]   Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase [J].
Rafati, S ;
Baba, AA ;
Bakhshayesh, M ;
Vafa, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01) :134-138
[23]   Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice:: the partial protection relies on interferon gamma producing CD8+ T lymphocyte activation [J].
Rafati, S ;
Kariminia, A ;
Seyde-Eslami, S ;
Narimani, M ;
Taheri, T ;
Lebbatard, M .
VACCINE, 2002, 20 (19-20) :2439-2447
[24]   A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major [J].
Rafati, S ;
Salmanian, AH ;
Taheri, T ;
Vafa, M ;
Fasel, N .
VACCINE, 2001, 19 (25-26) :3369-3375
[25]   Identification of Leishmania major cysteine proteinases as targets of the immune response in humans [J].
Rafati, S ;
Salmanian, AH ;
Hashemi, K ;
Schaff, C ;
Belli, S ;
Fasel, N .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 113 (01) :35-43
[26]  
SACKS DL, 1987, J IMMUNOL, V138, P908
[27]  
SANDERSON S, 2000, BIOCHEM J, V374, P383
[28]  
Sjölander A, 1998, J IMMUNOL, V160, P3949
[29]   A RECOMBINANT LEISHMANIA ANTIGEN THAT STIMULATES HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO EXPRESS A TH1-TYPE CYTOKINE PROFILE AND TO PRODUCE INTERLEUKIN-12 [J].
SKEIKY, YAW ;
GUDERIAN, JA ;
BENSON, DR ;
BACELAR, O ;
CARVALHO, EM ;
KUBIN, M ;
BADARO, R ;
TRINCHIERI, G ;
REED, SG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1527-1537
[30]   IMMUNE-RESPONSES OF LEISHMANIASIS PATIENTS TO HEAT-SHOCK PROTEINS OF LEISHMANIA SPECIES AND HUMANS [J].
SKEIKY, YAW ;
BENSON, DR ;
GUDERIAN, JA ;
WHITTLE, JA ;
BACELAR, O ;
CARVALHO, EM ;
REED, SG .
INFECTION AND IMMUNITY, 1995, 63 (10) :4105-4114